United States: Private Ruling Endorses Taxpayer-Friendly Reading Of "Qualified Small Business" Under Section 1202

On September 5, 2014, the Internal Revenue Service ("IRS") released Private Letter Ruling 201436001 (the "Ruling"), which found that a company providing products and services primarily within the pharmaceutical industry was a "qualified trade or business" for purposes of Section 1202(e)(3).1 The IRS had never before issued guidance on the definition of "qualified small business stock" ("QSBS") under Section 1202.2 A private letter ruling is not binding on the IRS except as to the taxpayer that requested and received the ruling, and cannot be relied upon as precedent by other taxpayers. Nonetheless, a private letter ruling typically provides all taxpayers with some indication of the IRS position on the particular legal issue that was addressed in the context of the facts contained in the ruling.


Section 1202 allows an individual shareholder who has held QSBS for more than five years to receive tax-reduced or tax-free gain up to the greater of $10 million or 10 times the shareholder's basis in the QSBS.3 In order for a shareholder's stock to qualify as QSBS, it must have been issued by a "qualified small business" ("QSB") and it must have been acquired by the shareholder at original issuance (or in certain limited non-recognition transactions).4 Among other requirements, a corporation can be a QSB only if at least 80 percent of its assets are used in the active conduct of at least one "qualified trade or business."5 The Ruling is of particular interest because it gives substantive consideration to the meaning of the term "qualified trade or business."


The facts of the Ruling involved a company that operated in the pharmaceutical industry and aided clients in the commercialization of experimental drugs. The company's main business activities were researching the effectiveness of drug formulations, conducting clinical tests, and manufacturing drugs. The company also helped clients develop successful drug-manufacturing processes and solve other problems encountered in the pharmaceutical industry. The company's assets included manufacturing and clinical facilities along with intellectual property assets, such as a patent portfolio. The company also possessed several valuable relationships in the pharmaceutical industry.

The taxpayer in the Ruling had recently disposed of some stock in the company and asked the IRS to rule on whether the company was engaged in a "qualified trade or business" within the meaning of Section 1202(e)(3). Section 1202(e)(3) defines a "qualified trade or business" as any business other than a trade or business that:

  • involves performing services in the field of health, law, engineering, architecture, accounting, actuarial science, performing arts, athletics, financial services, brokerage services, or consulting;
  • has as its principal asset the reputation or skill of one or more of its employees;
  • operates in the field of finance, insurance, banking, investing, leasing, farming, or mining; or
  • runs a hotel, motel, restaurant, or similar business.

In analyzing whether the company was engaged in a "qualified trade or business" under Section 1202(e)(3), the IRS explained that "the thrust of § 1202(e)(3) is that businesses are not qualified trades or businesses if they offer value to customers primarily in the form of services, whether those services are the providing of hotel rooms, for example, or in the form of individual expertise (law firm partners)." The IRS noted that the company in the Ruling used its specific manufacturing and intellectual property assets to create value for customers, and was akin to a manufacturer of parts in the automobile industry. Accordingly, despite recognizing the company's clear connections to the pharmaceutical industry, which is a component of the "health" industry (a clearly prohibited field), the IRS ruled that the company's activities did not amount to the performance of services in the health industry within the meaning of Section 1202(e)(3). The Ruling specifically noted that the "Company is not in the business of offering service in the form of individual expertise."


The Ruling is significant because it should offer some insight into the government's general view of the meaning of "qualified trade or business" under Section 1202(e)(3). The plain language of the statute might have been read more broadly to exclude clinical testing and drug research as activities equivalent to the performance of services in the health industry. The Ruling's narrower interpretation of the exclusions in Section 1202(e)(3) at a minimum should provide many pharmaceutical companies with a favorable outlook as to their QSB eligibility.

The Ruling does not directly address the meaning of the language in Section 1202(e)(3) which excludes from the definition of "qualified trade or business" a company whose "principal asset . . . is the reputation or skill of one or more of its employees."6 Taxpayers frequently question the scope of this provision, wondering whether this phrase might encompass all start-up companies with few hard assets on their books because they must rely heavily on key employees to establish and maintain business value, or whether the term is limited to companies engaged in inherently service-based businesses.7 Although the Ruling does not provide a direct answer to this question, it does explain that the "reputation or skill" provision "works to exclude, for example, consulting firms, law firms, and financial asset management firms" and that the "thrust" of Section 1202(e)(3) is to exclude businesses whose primary value generator is services. Given the Owen case discussed in footnote 7 above, and the rationale of the Ruling, in appropriate circumstances it would seem reasonable for a start-up that is not engaged in one of the specifically excluded businesses to argue that it is a QSB even though it relies heavily on the skill and expertise of its employees, particularly where their efforts are necessary in order to develop valuable intangible assets that ultimately will go on to represent the bulk of the value of the company.


Section 1202 has often been criticized by commentators as not offering sufficient benefits to investors to justify its substantial limitations. However, legislative changes made in 2010 allow taxpayers who acquired QSBS between September 2010 and December 2013 to exclude 100 percent of their gain when they sell their QSBS, subject to the $10 million or 10-times-basis limits described above (and to avoid the AMT clawback). In addition, bills that have been introduced recently in the Senate would extend the 100 percent exclusion either temporarily or permanently.8 A temporary or permanent extension of the 100 percent gain exclusion, combined with a favorable definition of "qualified trade or business," definitely would make Section 1202 a more beneficial provision for entrepreneurs and investors who are considering how to form a new business venture.

This publication has been prepared for general informational purposes only. None of the statements made herein constitute financial, accounting, tax, or other professional advice of any kind. Please consult with your own advisors to discuss matters relevant to your specific situation.


1 P.L.R. 201436001 (May 22, 2014).

2 All Section or § references herein are to sections of the Internal Revenue Code of 1986, as amended, unless otherwise indicated.

3 See Section 1202(a)(1). Provided all of the other requirements are met, taxpayers who acquired QSBS before 2009 or after 2013 are eligible to exclude 50 percent of their gain from tax, subject to the alternative minimum tax ("AMT") clawback; those who acquired QSBS between February 2009 and September 2010 are eligible for 75 percent exclusion, subject to AMT clawback; and those who acquired QSBS between September 2010 and December 2013 are eligible for 100 percent gain exclusion, with no AMT clawback. As noted in the text accompanying footnote 8, infra, pending legislative proposals would reinstate the 100 percent gain exclusion either permanently or temporarily.

4 See Sections 1202(c)(1) and (h). For additional discussion of the requirements applicable to QSBS and Section 1202 generally, see MoFo Client Alert: Recent Changes Allow Tax-Free Receipt of up to $10 Million in Gain from the Sale of Small Business Stock, Jan. 17, 2013, available at http://media.mofo.com/files/Uploads/Images/130116-Sale-of-Small-Business-Stock.pdf; Bernie Pistillo and Maureen Linch, Recent Changes Make Qualified Small Business Stock Rules Attractive for Shares Acquired during 2013, NVCA Today, Feb. 25, 2013, available at http://nvcatoday.nvca.org/index.php/from-our-sponsors/recent-changes-make-qualified-small-business-stock-rules-attractive-for-shares-acquired-during-2013.html; David Strong, Section 1202 Qualified Small Business Stock, Aug. 11, 2011, available at http://media.mofo.com/files/Uploads/Images/110811-Section-1202-Qualified-Small-Business-Stock.pdf.

5 Section 1202(e)(1).

6 Section 1202(e)(3)(A).

7 The legislative history of Section 1202 also does not answer this question. The only authority we are aware of that discusses the point is a Tax Court memorandum opinion, John P. Owen, T.C. Memo. 2012-21, which in dicta dismisses an attempt by the government to disqualify a corporation as a QSB because of the importance of the founder's skill to the business. The case involved a company that created and sold insurance-related financial products. The founder was a seasoned insurance salesman with 40 years of experience in insurance sales. The IRS argued that the company did not qualify because of the "reputation or skill" language in Section 1202(e)(3) since the founder's skill was one of its principal assets of the business, but the court disagreed, explaining that even though the founder's skill did contribute to the success of the business, it was not an asset of the company.

8 The Expiring Provisions Improvement, Reform, and Efficiency Act of 2014, introduced on April 28, 2014, would extend the 100 percent gain exclusion to QSBS acquired until January 2016. S. 2260, 113th Cong. § 136 (2d Sess. 2014). The Buy it in America Act, introduced on July 29, 2014, would permanently extend the 100 percent gain exclusion to QSBS acquired any time after September 2010. S. 2680, 113th Cong. § 4 (2d Sess. 2014).

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Maureen E. Linch
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions